Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation

Published:2013-12 Issue:12 Volume:19 Page:1670-1676
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lanza Francesco,Campioni Diana C.,Hellmann Andrzej,Milone Giuseppe,Wahlin Anders,Walewski Jan,Spedini Pierangelo,Fiamenghi Cristina,Cuneo Antonio,Knopińska Wanda,Swierkowska-Czeneszew Monica,Petriz Jordi,Fruehauf Stefan,Farge Dominique,Mohty Mohamad,Passweg Jacob,Ruuto Tapani,Madrigal Alejandro,Johnsen Hans E.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Individual quality assessment of autografting by probability evaluation: A model estimated by analysis of graft-related endpoints in 204 patients with malignancies;Baech;Bone Marrow Transplant,2003

2. Quality assessment of autografting by probability evaluation: model estimation by clinical endpoints in newly diagnosed multiple myeloma patients;Roer;Cytotherapy,2006

3. What is quality in a transplant program?;LeMaistre;Biol Blood Marrow Transplant,2005

4. Trends of hematopoietic stem cell transplantation in the third millennium;Gratwohl;Curr Opin Hematol,2009

5. The ISHAGE guidelines for CD34+ cell determination by flow cytometry;Sutherland;J Hematother,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation;Cytometry Part B: Clinical Cytometry;2024-06-28

2. Evaluation of AQUIOS STEM, a novel method for automated CD34+ stem cell enumeration using flow cytometry;International Journal of Laboratory Hematology;2024-02-29

3. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24

4. Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt;Virology Journal;2023-02-04

5. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022